Fredun Pharmaceuticals Ltd — Updates, 30-07-2025: Company Update

The company's board has approved the financial results for the quarter ended June 30, 2025. Additionally, following input from its Nomination and Remuneration Committee, the board appointed two new independent directors: Mr. Anshu Agarwal and Ms. Sonal Desai. Both have been appointed for a five-year term, effective immediately, pending shareholder approval. These appointments aim to strengthen the board's independent oversight, enhancing corporate governance and strategic guidance for the company's operations. This is a key development for stakeholders.